niacinamide 3.4 MG/ML
- RxCUI
- 1305190
- RxNorm name
- niacinamide 3.4 MG/ML
- Term type
- SCDC
- Status
- Active
- Updated
- 2026-07-22 07:08:34
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092012
- Active start
- 092012
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 3.4 MG / 1 ML | niacinamide |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| niacinamide | 7405 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | niacinamide 3.4 MG/ML | NAMES |
| RxNorm Name | niacinamide 3.4 MG/ML | NAMES |
| TTY | SCDC | ATTRIBUTES |
| RxCUI | 1305190 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A11HA | Other plain vitamin preparations | ATC1-4 | niacinamide | |
| MEDRT | D009536 | Niacinamide | CHEM | has_ingredient | niacinamide |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_prevent | niacinamide |
| MEDRT | D003967 | Diarrhea | DISEASE | induces | niacinamide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | niacinamide |
| MEDRT | D005414 | Flatulence | DISEASE | induces | niacinamide |
| MEDRT | D005483 | Flushing | DISEASE | induces | niacinamide |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | niacinamide |
| MEDRT | D006937 | Hypercholesterolemia | DISEASE | may_treat | niacinamide |
| MEDRT | D015228 | Hypertriglyceridemia | DISEASE | may_treat | niacinamide |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | niacinamide |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | niacinamide |
| MEDRT | D010383 | Pellagra | DISEASE | may_treat | niacinamide |
| MEDRT | D010383 | Pellagra | DISEASE | may_prevent | niacinamide |
| MEDRT | D010437 | Peptic Ulcer | DISEASE | ci_with | niacinamide |
| MEDRT | D016491 | Peripheral Vascular Diseases | DISEASE | may_treat | niacinamide |
| MEDRT | N0000000231 | Enzyme Activators | MOA | has_moa | niacinamide |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | niacinamide |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | niacinamide |
| MEDRT | N0000008555 | Decreased Cholesterol Synthesis | PE | has_pe | niacinamide |
| MEDRT | N0000008687 | Decreased Lipogenesis | PE | has_pe | niacinamide |
| MEDRT | N0000009061 | Glucose Metabolism Alteration | PE | has_pe | niacinamide |
| MEDRT | N0000009345 | Increased Glycogenolysis | PE | has_pe | niacinamide |
| MEDRT | N0000009399 | Increased Metabolic Rate | PE | has_pe | niacinamide |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | niacinamide |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | HYBRID |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | STRENGTH | 3.4 MG/ML |
| ATTRIBUTES | TTY | SCDC |
| CODES | RxCUI | 1305190 |
| NAMES | RXNAV_STR | niacinamide 3.4 MG/ML |
| NAMES | RxNorm Name | niacinamide 3.4 MG/ML |